Top

28-02-2024 | Review

A Review of Healthcare-Associated Fungal Outbreaks in Children

Authors: Cyntia Ibanes-Gutiérrez, Aarón Espinosa-Atri, Ana Cecilia Carbajal-César

Published in: Current Fungal Infection Reports

Abstract

Purpose of Review

The aim of this review is to examine healthcare-associated fungal outbreaks (HAFO) in children. Our primary objective is to dissect epidemiology and etiology aspects to contribute to the investigation, prevention, and control of HAFO in pediatric settings.

Recent Findings

Latest studies have highlighted an increase in fungal infections among hospitalized children. These studies have revealed the involvement of environmental sources and cross-transmission through healthcare workers in the development of outbreaks. The diagnosis of fungal infections poses challenges, as does outbreak control due to non-routine surveillance and resistance of fungi to disinfectants and therapeutic drugs.

Summary

Recognition of risk factors, etiologic agents, diagnostic methods, and types of transmission that facilitate fungal infections in children is crucial to understand the importance of prompt outbreak investigation and control. Addressing research gaps in disinfection technologies and exploring the potential application of artificial intelligence on outbreak anticipation could aid in mitigating the impact of HAFO on pediatric populations.

•• Suleyman G, Alangaden GJ. Nosocomial fungal infections: epidemiology, infection control, and prevention. Infect Dis Clin North Am. 2021;35(4):1027–53. https://doi.org/10.1016/j.idc.2021.08.002. A complete overview of the impact of healthcare-associated fungal infections that focuses on etiologic agents, diagnostic methods and prevention strategies.CrossRefPubMed

Vazquez JA, Miceli MH, Alangaden G. Invasive fungal infections in transplant recipients. Ther Adv Infect Dis. 2013;1(3):85–105. https://doi.org/10.1177/2049936113491936.CrossRefPubMedPubMedCentral

Patterson TF, Thompson GR III, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice guidelines for the diagnosis and management of Aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63(4):e1-60. https://doi.org/10.1093/cid/ciw326.CrossRefPubMedPubMedCentral

Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candiadiasis; 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1-50. https://doi.org/10.1093/cid/civ933.CrossRefPubMed

Weiner-Lastinger L, Abner S, Edwards J, Kallen AJ, Karlsson M, Magill SS, et al. Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: summary of data reported to the National Healthcare Safety Network, 2015–2017. Infect Control Hosp Epidemiol. 2020;41(1):1–18. https://doi.org/10.1017/ice.2019.296.CrossRefPubMed

Litvintseva AP, Brandt ME, Mody RK, Lockhart SR. Investigating fungal outbreaks in the 21st century. PLoS Pathog. 2015;11(5):e1004804. https://doi.org/10.1371/journal.ppat.1004804.CrossRefPubMedPubMedCentral

Tsay S, Williams S, Mu Y, Epson E, Johnston H, Farley MM, et al. National burden of candidemia, United States. Open Forum. Infect Dis. 2018;5(Suppl 1):S142–3. https://doi.org/10.1093/ofid/ofy210.374.CrossRef

Centers for Disease Control and Prevention. Infection prevention and control. In: Candida auris. 2023. Available from: https://www.cdc.gov/fungal/candida-auris/c-auris-infection-control.html#disinfection. Accessed 02 Oct 2023.

Ha YE, Peck KR, Joo EJ, Kim SW, Jung SI, Chang HH, et al. Impact of first-line antifungal agents on the outcomes and costs of candidemia. Antimicrobial Agents Chemother. 2012;56(7):3950–6. https://doi.org/10.1128/AAC.06258-11.CrossRef

10.

Benedict K, Richardson M, Vallabhaneni S, Jackson BR, Chiller T. Emerging issues, challenges, and changing epidemiology of fungal disease outbreaks. Lancet Infect Dis. 2017;17(12):e403–11. https://doi.org/10.1016/S1473-3099(17)30443-7.CrossRefPubMedPubMedCentral

11.

Yapar N. Epidemiology and risk factors for invasive candidiasis. Ther Clin Risk Manag. 2014;10:95–105. https://doi.org/10.2147/TCRM.S40160.CrossRefPubMedPubMedCentral

12.

Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant. 2009;15(10):1143–238. https://doi.org/10.1016/j.bbmt.2009.06.019.CrossRefPubMedPubMedCentral

13.

Perlroth J, Choi B, Spellberg B. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol. 2007;45(4):321–46. https://doi.org/10.1080/13693780701218689.CrossRefPubMed

14.

Kanamori H, Rutala WA, Sickbert-Bennett EE, Weber DJ. Review of fungal outbreaks and infection prevention in healthcare settings during construction and renovation. Clin Infect Dis. 2015;61:433–44. https://doi.org/10.1093/cid/civ297.CrossRefPubMed

15.

Haiduven D. Nosocomial aspergillosis and building construction. Med Mycol. 2009;47(suppl 1):S210–6. https://doi.org/10.1080/13693780802247694.CrossRefPubMed

16.

Sabino R, Veríssimo C, Pereira ÁA, Antunes F. Candida auris, an agent of hospital-associated outbreaks: which challenging issues do we need to have in mind? Microorganisms. 2020;8(2):181. https://doi.org/10.3390/microorganisms8020181.CrossRefPubMedPubMedCentral

17.

Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53(1):41–4. https://doi.org/10.1111/j.1348-0421.2008.00083.x.CrossRefPubMed

18.

Centers for Disease Control and Prevention. Tracking Candida auris. In: Candida auris. 2023. Available from: https://www.cdc.gov/fungal/candida-auris/tracking-c-auris.html. Accessed 10 Nov 2023.

19.

Berrio I, Caceres DH, Coronell RW, Salcedo S, Mora L, Marin A, et al. Bloodstream infections with Candida auris among children in Colombia: clinical characteristics and outcomes of 34 cases. J Pediatric Infect Dis Soc. 2021;10(2):151–4. https://doi.org/10.1093/jpids/piaa038.CrossRefPubMed

20.

Vallabhaneni S, Kallen A, Tsay S, Chow N, Welsh R, Kerins J, et al. Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus - United States, May 2013-August 2016. MMWR Morb Mortal Wkly Rep. 2016;65(44):1234–7. https://doi.org/10.15585/mmwr.mm6544e1.CrossRefPubMed

21.

Schelenz S, Hagen F, Rhodes JL, Abdolrasouli A, Chowdhary A, Hall A, et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control. 2016;5:35. https://doi.org/10.1186/s13756-016-0132-5.CrossRefPubMedPubMedCentral

22.

Piedrahita CT, Cadnum JL, Jencson AL, Shaikh AA, Ghannoum MA, Donskey CJ. Environmental surfaces in healthcare facilities are a potential source for transmission of candida auris and other Candida species. Infect Control Hosp Epidemiol. 2017;38(9):1107–9. https://doi.org/10.1017/ice.2017.127.CrossRefPubMed

23.

Welsh RM, Bentz ML, Shams A, Houston H, Lyons A, Rose LJ, et al. Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care surface. J Clin Microbiol. 2017;55(10):2996–3005. https://doi.org/10.1128/JCM.00921-17.CrossRefPubMedPubMedCentral

24.

Bergeron G, Bloch D, Murray K, Kratz M, Parton H, Ackelsberg J, et al. Candida auris colonization after discharge to a community setting: New York City, 2017–2019. Open Forum Infect Dis. 2020;8(1):ofaa620. https://doi.org/10.1093/ofid/ofaa620.CrossRefPubMedPubMedCentral

25.

Ambaraghassi G, Dufresne PJ, Dufresne SF, Vallieres E, Munoz JF, Cuomo CA, et al. Identification of Candida auris by use of the updated vitek 2 yeast identification system, version 8.01: a multilaboratory evaluation study. J Clin Microbiol. 2019;57(11):e00884-19. https://doi.org/10.1128/JCM.00884-19.CrossRefPubMedPubMedCentral

26.

Ayala-Gaytán JJ, Montoya AM, Martínez-Resendez MF, Guajardo-Lara CE, de J Treviño-Rangel R, Salazar-Cavazos L, et al. First case of Candida auris isolated from the bloodstream of a Mexican patient with serious gastrointestinal complications from severe endometriosis. Infection. 2021;49(3):523–5. https://doi.org/10.1007/s15010-020-01525-1.CrossRefPubMed

27.

Liao Y, Lu X, Yang S, Luo Y, Chen Q, Yang R. Epidemiology and outcome of Trichosporon Fungemia: a review of 185 reported cases from 1975 to 2014. Open Forum Infect Dis. 2015;2(4):ofv141. https://doi.org/10.1093/ofid/ofv141.CrossRefPubMedPubMedCentral

28.

Ruan SY, Chien JY, Hsueh PR. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan. Clin Infect Dis. 2009;49(1):e11–7. https://doi.org/10.1086/599614.CrossRefPubMed

29.

Rhimi W, Theelen B, Boekhout T, Otranto D, Cafarchia C. Malassezia spp. Yeasts of emerging concern in fungemia. Front Cell Infect Microbiol. 2020;10:370. https://doi.org/10.3389/fcimb.2020.00370.CrossRefPubMedPubMedCentral

30.

Guducuoglu H, Gultepe B, Otlu B, Bektas A, Yildirim O, Tuncer O, et al. Candida albicans outbreak associated with total parenteral nutrition in the neonatal unit. Indian J Med Microbiol. 2016;34:202–7. https://doi.org/10.4103/0255-0857.180303.CrossRefPubMed

31.

Qi L, Fan W, Xia X, Yao L, Liu L, Zhao H, et al. Nosocomial outbreak of Candida parapsilosis sensu stricto fungaemia in a neonatal intensive care unit in China. J Hosp Infect. 2018;100(4):e246–52. https://doi.org/10.1016/j.jhin.2018.06.009.CrossRefPubMed

32.

van Schalkwyk E, Iyaloo S, Naicker SD, Maphanga TG, Mpembe RS, Zulu TG, et al. Large outbreaks of fungal and bacterial bloodstream infections in a neonatal unit, South Africa, 2012–2016. Emerg Infect Dis. 2018;24(7):1204–12. https://doi.org/10.3201/eid2407.171087.CrossRefPubMedPubMedCentral

33.

Calvo B, Melo AS, Perozo-Mena A, Hernandez M, Francisco EC, Hagen F, et al. First report of Candida auris in America: clinical and microbiological aspects of 18 episodes of candidemia. J Infect. 2016;73(4):369–74. https://doi.org/10.1016/j.jinf.2016.07.008.CrossRefPubMed

34.

Chakrabarti A, Singh S. Multidrug-resistant Candida auris: an epidemiological review. Expert Rev Anti Infect Ther. 2020;18(6):551–62. https://doi.org/10.1080/14787210.2020.1750368.CrossRefPubMed

35.

Vashishtha VM, Mittal A, Garg A. A fatal outbreak of Trichosporon asahii sepsis in a neonatal intensive care Unit. Indian Pediatr. 2012;49(9):745–7. https://doi.org/10.1007/s13312-012-0137-y.CrossRefPubMed

36.

Chow NA, Chinn R, Pong A, Schultz K, Kim J, Gade L, et al. Use of whole-genome sequencing to detect an outbreak of Malassezia pachydermatis infection and colonization in a neonatal intensive care unit-California, 2015–2016. Infect Control Hosp Epidemiol. 2020;41(7):851–3. https://doi.org/10.1017/ice.2020.73.CrossRefPubMed

37.

Vonberg RP, Gastmeier P. Nosocomial aspergillosis in outbreak settings. J Hosp Infect. 2006;63(3):246–54. https://doi.org/10.1016/j.jhin.2006.02.014.CrossRefPubMed

38.

Francis JR, Villanueva P, Bryant P, Blyth CC. Mucormycosis in children: review and recommendations for management. J Pediatric Infect Dis Soc. 2018;7(2):159–64. https://doi.org/10.1093/jpids/pix107.CrossRefPubMed

39.

Litvinov N, da Silva MT, van der Heijden IM, Graça MG, Marques de Oliveira L, Fu L, et al. An outbreak of invasive fusariosis in a children’s cancer hospital. Clin Microbiol Infect. 2015;21(3):268.e1-7. https://doi.org/10.1016/j.cmi.2014.09.004.CrossRefPubMed

40.

Carlesse F, Amaral AC, Gonçalves SS, Xafranski H, Lee MM, Zecchin V, et al. Outbreak of Fusarium oxysporum infections in children with cancer: an experience with 7 episodes of catheter-related fungemia. Antimicrob Resist Infect Control. 2017;7(6):93. https://doi.org/10.1186/s13756-017-0247-3.CrossRef

41.

Mitchell SJ, Gray J, Morgan ME, Hocking MD, Durbin GM. Nosocomial infection with Rhizopus microsporus in preterm infants: association with wooden tongue depressors. Lancet. 1996;348(9025):441–3. https://doi.org/10.1016/s0140-6736(96)05059-3.CrossRefPubMed

42.

Garner D, Machin K. Investigation and management of an outbreak of mucormycosis in a paediatric oncology unit. J Hosp Infect. 2008;70(1):53–9. https://doi.org/10.1016/j.jhin.2008.05.017.CrossRefPubMed

43.

Duffy J, Harris J, Gade L, Sehulster L, Newhouse E, O’Connell H, et al. Mucormycosis outbreak associated with hospital linens. Pediatr Infect Dis J. 2014;33(5):472–6. https://doi.org/10.1097/INF.0000000000000261.CrossRefPubMed

44.

El-Mahallawy HA, Khedr R, Taha H, Shalaby L, Mostafa A. Investigation and management of a rhizomucor outbreak in a pediatric cancer Hospital in Egypt. Pediatr Blood Cancer. 2016;63(1):171–3. https://doi.org/10.1002/pbc.25673.CrossRefPubMed

45.

Dicker RC, Coronado F, Koo D, Parrish RG. Principles of epidemiology in public health practice: An Introduction to Applied Epidemiology and Biostatistics. In: Self-study course. 3rd ed. Atlanta: CDC; 2006. SS1000.

46.

Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, et al. Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis. 2020;71(6):1367–76. https://doi.org/10.1093/cid/ciz1008.CrossRefPubMed

47.

Arvanitis M, Anagnostou T, Fuchs BB, Caliendo AM, Mylonakis E. Molecular and nonmolecular diagnostic methods for invasive fungal infections. Clin Microbiol Rev. 2014;27(3):490–526. https://doi.org/10.1128/CMR.00091-13.CrossRefPubMedPubMedCentral

48.

Fisher JF. Candida urinary tract infections epidemiology, pathogenesis, diagnosis, and treatment: executive summary. Clin Infect Dis. 2011;52(Suppl 6):S429–32. https://doi.org/10.1093/cid/cir108.CrossRefPubMed

49.

Guegan H, Robert-Gangneux F, Camus C, Belaz S, Marchand T, Baldeyrou M, et al. Improving the diagnosis of invasive aspergillosis by the detection of Aspergillus in broncho-alveolar lavage fluid: comparison of non-culture-based assays. J Infect. 2018;76(2):196–205. https://doi.org/10.1016/j.jinf.2017.11.011.CrossRefPubMed

50.

• Mendonça A, Santos H, Franco-Duarte R, Sampaio P. Fungal infections diagnosis - past, present and future. Res Microbiol. 2022;173(3):103915. https://doi.org/10.1016/j.resmic.2021.103915. A review of diagnostic methods for fungal identification, crucial for outbreak detection and control.CrossRefPubMed

51.

Scharmann U, Kirchhoff L, Chapot VleS, Dziobaka J, Verhasselt HL, Stauf R, et al. Comparison of four commercially available chromogenic media to identify Candida albicans and other medically relevant Candida species. Mycoses. 2020;63(8):823–31. https://doi.org/10.1111/myc.13119.CrossRefPubMed

52.

Sehulster L, Chinn RY, CDC, HICPAC. Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep. 2003;52(RR-10):1–42.PubMed

53.

Karabıçak N, Uludağ Altun H, Karatuna O, Hazırolan G, Aksu N, Adiloğlu A, et al. Evaluation of common commercial systems for the identification of yeast isolates in microbiology laboratories: a multicenter study. Mikrobiyol Bul. 2015;49(2):210–20. https://doi.org/10.5578/mb.9370.CrossRefPubMed

54.

Yi Q, Xiao M, Fan X, Zhang G, Yang Y, Zhang JJ, et al. Evaluation of Autof MS 1000 and vitek MS MALDI-TOF MS system in identification of closely-related yeasts causing invasive fungal diseases. Front Cell Infect Microbiol. 2021;11(11):628828. https://doi.org/10.3389/fcimb.2021.628828.CrossRefPubMedPubMedCentral

55.

Lu Y, Hatch J, Holmberg K, Hurlock A, Drobysheva D, Spaulding U, et al. Multi-center evaluation of the BioFire® FilmArray® Blood culture identification 2 panel for the detection of microorganisms and resistance markers in positive blood cultures. Open Forum Infect Dis. 2019;6(Suppl 2):S299-300. https://doi.org/10.1093/ofid/ofz360.719.CrossRefPubMedCentral

56.

Racil Z, Kocmanova I, Lengerova M, Weinbergerova B, Buresova L, Toskova M, et al. Difficulties in using 1,3-b-D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies high frequency of false positive results and their analysis. J Med Microbiol. 2010;59(Pt 9):1016–22. https://doi.org/10.1099/jmm.0.019299-0.CrossRefPubMed

57.

Wang K, Luo Y, Zhang W, Xie S, Yan P, Liu Y, et al. Diagnostic value of Candida mannan antigen and anti-mannan IgG and IgM antibodies for Candida infection. Mycoses. 2020;63(2):181–8. https://doi.org/10.1111/myc.13035.CrossRefPubMed

58.

Dichtl K, Seybold U, Ormanns S, Horns H. Evaluation of a novel Aspergillus antigen enzyme-linked immunosorbent assay. J Clin Microbiol. 2019;57(7):e00136-e219. https://doi.org/10.1128/JCM.00136-19.CrossRefPubMedPubMedCentral

59.

Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, Garey KW, Alangaden GJ, Vazquez JA, et al. T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clin Infect Dis. 2015;60(6):892–9. https://doi.org/10.1093/cid/ciu959.CrossRefPubMed

60.

Alexander BD, Lamoth F, Heussel CP, Prokop CS, Desai SR, Morrissey CO, et al. Guidance on imaging for invasive pulmonary aspergillosis and mucormycosis: from the imaging working group for the revision and update of the consensus definitions of fungal disease from the EORTC/MSGERC. Clin Infect Dis. 2021;72(Suppl 2):S79–88. https://doi.org/10.1093/cid/ciaa1855.CrossRefPubMed

61.

• Abbas S, Stevens M. Horizontal vs vertical infection control strategies. In: Guide to infection control in the healthcare setting. International Society for Infectious Diseases. 2021. Available from: https://isid.org/guide/infectionprevention/infection-control-strategies/#:~:text=Infection%20control%20strategies%20designed%20to%20prevent%20the%20spread%20of%20healthcare,spread%20of%20multiple%20organisms%20simultaneously. Accessed 31 Oct 2023. Guidance on different strategies to prevent healthcare-associated infections both, those directed towards specific pathogens and those useful against the spread of multiple microorganisms.

62.

Biswal M, Rudramurthy SM, Jain N, Shamanth AS, Sharma D, Jain K, et al. Controlling a possible outbreak of Candida auris infection: lessons learnt from multiple interventions. J Hosp Infect. 2017;97(4):363–70. https://doi.org/10.1016/j.jhin.2017.09.009.CrossRefPubMed

63.

Rutala WA, Weber DJ. Disinfection, sterilization, and antisepsis: an overview. Am J Infect Control. 2019;47S:A3–9. https://doi.org/10.1016/j.ajic.2019.01.018.CrossRefPubMed

64.

de Groot T, Chowdhary A, Meis JF, Voss A. Killing of Candida auris by UV-C: Importance of exposure time and distance. Mycoses. 2019;62(5):408–12. https://doi.org/10.1111/myc.12903.CrossRefPubMedPubMedCentral

65.

Alberta Health Services Infection Prevention & Control. Use of fans and portable air conditioners in healthcare settings. 2023. Available from: https://www.albertahealthservices.ca/assets/healthinfo/ipc/if-hp-ipc-info-sheet-portable-fans.pdf. Accessed 29 Oct 2023.

66.

Tsay S, Kallen A, Jackson BR, Chiller TM, Vallabhaneni S. Approach to the investigation and management of patients with Candida auris, an emerging multidrug-resistant yeast. Clin Infect Dis. 2018;66(2):306–11. https://doi.org/10.1093/cid/cix744.CrossRefPubMed

67.

Olmsted RN. Prevention by design: construction and renovation of health care facilities for patient safety and infection prevention. Infect Dis Clin North Am. 2016;30(3):713–28. https://doi.org/10.1016/j.idc.2016.04.005.CrossRefPubMedPubMedCentral

68.

Centers for Disease Control and Prevention. Screening. In: Candida auris. 2023. Available from: https://www.cdc.gov/fungal/candida-auris/c-auris-screening.html. Accessed 04 Nov 2023.

69.

Baggio D, Peel T, Peleg AY, Avery S, Prayaga M, Foo M, et al. Closing the gap in surveillance and audit of invasive mold diseases for antifungal stewardship using machine learning. J Clin Med. 2019;8(9):1390. https://doi.org/10.3390/jcm8091390.CrossRefPubMedPubMedCentral

70.

Thadani NN, Gurev S, Notin P, Youssef N, Rollins NJ, Ritter D, et al. Learning from prepandemic data to forecast viral escape. Nature. 2023;622(7984):818–25. https://doi.org/10.1038/s41586-023-06617-0.ADSCrossRefPubMedPubMedCentral

Title: A Review of Healthcare-Associated Fungal Outbreaks in Children
Authors: Cyntia Ibanes-Gutiérrez
Aarón Espinosa-Atri
Ana Cecilia Carbajal-César
Publication date: 28-02-2024
Publisher: Springer US
Published in: Current Fungal Infection Reports
Print ISSN: 1936-3761
Electronic ISSN: 1936-377X
DOI: https://doi.org/10.1007/s12281-024-00491-7

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials